Henning Rainer

Title: Henning Rainer: Innovator in Calcium Antagonists

Introduction

Henning Rainer is a notable inventor based in Hattersheim am Main, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of calcium antagonists. His innovative work has led to the creation of new compounds that have potential therapeutic applications.

Latest Patents

Henning Rainer holds a patent for "3-phenyl indolinone derivatives, processes for their preparation." This patent describes calcium antagonists of a specific formula, where R(1), R(2), R(3), and R(4) can be various groups, including hydrogen, alkyl, alkoxy, and halogen. The synthesis involves reactions of new compounds with cyclic amino compounds and other derivatives, showcasing Rainer's expertise in chemical processes.

Career Highlights

Rainer is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical industry. His work at Hoechst has allowed him to focus on innovative research and development in the field of medicinal compounds. His contributions have been instrumental in advancing the understanding of calcium antagonists.

Collaborations

Henning Rainer has collaborated with notable colleagues, including Ulrich Lerch and Joachim Kaiser. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Henning Rainer's innovative work in the field of calcium antagonists and his contributions to medicinal chemistry highlight his importance as an inventor. His patent and collaborations reflect a commitment to advancing scientific knowledge and developing new therapeutic options.